IKBKB and neoplasm: The expression of a dominant mutant IKKβDN or targeted deletion of IKKβ in bone marrow derived or tumor-associated macrophages prevented those cells from enhancing tumor cell invasiveness in vitro, enhanced tumoricidal activity and IL-12-dependent NK cell recruitment.